In May 2017 Saiba Animal Health AG announced a merger with Saiba Animal Health GmbH. Saiba Animal Health’s CAD vaccine (partnered with Benchmark Holdings PLC) and product pipeline of novel vaccine candidates subsequently became part of HyopPet’s product candidate pipeline .
Read MoreBenchmark has secured an exclusive worldwide license from Saiba Animal Health GmbH, to develop and commercialise a recombinant vaccine for Canine Atopic Dermatitis (CAD) using Virus Like-Particle (VLP) technology. Link to full release from Benchmark
Read MoreBenchmark Holdings PLC, the international animal health, technical publishing and sustainability science business, announces that its Animal Health division has entered into an agreement with Saiba Animal Health AG (“Saiba Animal Health”). With an estimated 10% of the global population suffering from cat allergies, the agreement between Saiba Animal Health and Benchmark is designed to …
Read MoreZurich, 20 October 2013 – Saiba Animal Health, a spin-off of the University of Zurich, has joined the award ceremony in the category “Inventors” at this year’s Swiss Technology Awards. At the Swiss Innovation Forum 2013 in Basel, the team of renowned allergologists and immunologists Gabriela Senti, Martin Bachmann and Thomas Kündig received the trophy. …
Read More